These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

555 related articles for article (PubMed ID: 27540977)

  • 1. Circulating lncRNA H19 in plasma as a novel biomarker for breast cancer.
    Zhang K; Luo Z; Zhang Y; Zhang L; Wu L; Liu L; Yang J; Song X; Liu J
    Cancer Biomark; 2016 Jun; 17(2):187-94. PubMed ID: 27540977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Large intergenic non-coding RNA-ROR as a potential biomarker for the diagnosis and dynamic monitoring of breast cancer.
    Zhao T; Wu L; Li X; Dai H; Zhang Z
    Cancer Biomark; 2017 Aug; 20(2):165-173. PubMed ID: 28869448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating long noncoding RNA GAS5 as a potential biomarker in breast cancer for assessing the surgical effects.
    Han L; Ma P; Liu SM; Zhou X
    Tumour Biol; 2016 May; 37(5):6847-54. PubMed ID: 26662314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating long non-coding HOX transcript antisense intergenic ribonucleic acid in plasma as a potential biomarker for diagnosis of breast cancer.
    Zhang Y; Zhang K; Luo Z; Liu L; Wu L; Liu J
    Thorac Cancer; 2016 Nov; 7(6):627-632. PubMed ID: 27755794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of long non-coding RNA H19 and microRNA let7a expression on thyroid cancer prognosis.
    Liu N; Zhou Q; Qi YH; Wang H; Yang L; Fan QY
    Exp Mol Pathol; 2017 Aug; 103(1):71-77. PubMed ID: 28655518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the long non-coding RNA H19 in plasma as a novel biomarker for diagnosis of gastric cancer.
    Zhou X; Yin C; Dang Y; Ye F; Zhang G
    Sci Rep; 2015 Jun; 5():11516. PubMed ID: 26096073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection and analysis of circulating large intergenic non-coding RNA regulator of reprogramming in plasma for breast cancer.
    Zhang K; Luo Z; Zhang Y; Wang Y; Cui M; Liu L; Zhang L; Liu J
    Thorac Cancer; 2018 Jan; 9(1):66-74. PubMed ID: 29090518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Long non-coding RNA HOTAIR in plasma as a potential biomarker for breast cancer diagnosis].
    Zhang KJ; Zhang Y; Luo ZL; Liu L; Yang J; Wu LC; Yu SS; Liu JB
    Nan Fang Yi Ke Da Xue Xue Bao; 2016 Apr; 36(4):488-92. PubMed ID: 27113175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating DNA of HOTAIR in serum is a novel biomarker for breast cancer.
    Zhang L; Song X; Wang X; Xie Y; Wang Z; Xu Y; You X; Liang Z; Cao H
    Breast Cancer Res Treat; 2015 Jul; 152(1):199-208. PubMed ID: 26033707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the Role of Circulating Long Non-Coding RNA H19 as a Promising Novel Biomarker in Plasma of Patients with Gastric Cancer.
    Hashad D; Elbanna A; Ibrahim A; Khedr G
    J Clin Lab Anal; 2016 Nov; 30(6):1100-1105. PubMed ID: 27184562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Significance of Long Non-coding RNA MALAT1 Expression in Tissue and Serum of Breast Cancer.
    Miao Y; Fan R; Chen L; Qian H
    Ann Clin Lab Sci; 2016 Jul; 46(4):418-24. PubMed ID: 27466303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of high expression of circulating serum lncRNA RP11-445H22.4 in breast cancer patients: a Chinese population-based study.
    Xu N; Chen F; Wang F; Lu X; Wang X; Lv M; Lu C
    Tumour Biol; 2015 Sep; 36(10):7659-65. PubMed ID: 25929808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. H19 serves as a diagnostic biomarker and up-regulation of H19 expression contributes to poor prognosis in patients with gastric cancer.
    Chen JS; Wang YF; Zhang XQ; Lv JM; Li Y; Liu XX; Xu TP
    Neoplasma; 2016; 63(2):223-30. PubMed ID: 26774144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of Serum Exosomal H19 as a Noninvasive Biomarker for Bladder Cancer Diagnosis and Prognosis.
    Wang J; Yang K; Yuan W; Gao Z
    Med Sci Monit; 2018 Dec; 24():9307-9316. PubMed ID: 30576305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interplay of lncRNA H19/miR-675 and lncRNA NEAT1/miR-204 in breast cancer.
    Müller V; Oliveira-Ferrer L; Steinbach B; Pantel K; Schwarzenbach H
    Mol Oncol; 2019 May; 13(5):1137-1149. PubMed ID: 30803129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. H19 lncRNA mediates 17β-estradiol-induced cell proliferation in MCF-7 breast cancer cells.
    Sun H; Wang G; Peng Y; Zeng Y; Zhu QN; Li TL; Cai JQ; Zhou HH; Zhu YS
    Oncol Rep; 2015 Jun; 33(6):3045-52. PubMed ID: 25846769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of Serum Exosomal H19 as a Noninvasive Biomarker for Breast Cancer Diagnosis.
    Zhong G; Wang K; Li J; Xiao S; Wei W; Liu J
    Onco Targets Ther; 2020; 13():2563-2571. PubMed ID: 32273726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential Diagnostic Value of Plasma Long-Chain Non-Coding RNA HIT in Breast Cancer.
    Hou H; Li F; Yang W; Wang H
    Clin Lab; 2019 Aug; 65(8):. PubMed ID: 31414748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased serum miR-181a is a potential new tool for breast cancer screening.
    Guo LJ; Zhang QY
    Int J Mol Med; 2012 Sep; 30(3):680-6. PubMed ID: 22692639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating exosomal long non-coding RNA H19 as a potential novel diagnostic and prognostic biomarker for gastric cancer.
    Zhou H; Shen W; Zou H; Lv Q; Shao P
    J Int Med Res; 2020 Jul; 48(7):300060520934297. PubMed ID: 32660285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.